Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.74B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$760M |
| 3 |
Alibaba
BABA
|
+$429M |
| 4 |
Stellantis
STLA
|
+$372M |
| 5 |
CERN
Cerner Corp
CERN
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.85B |
| 2 |
Microsoft
MSFT
|
+$1.75B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.22B |
| 4 |
Amazon
AMZN
|
+$1.04B |
| 5 |
iShares US Real Estate ETF
IYR
|
+$924M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.06% |
| 2 | Financials | 14.44% |
| 3 | Healthcare | 10.25% |
| 4 | Consumer Discretionary | 9.7% |
| 5 | Communication Services | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Iovance Biotherapeutics
IOVA
$1.95B
| $1.22M | ﹤0.01% |
73,264
+67,312
| +1,131% | +$1.04M |
|
|
OYST
2177
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $1.22M | ﹤0.01% |
+104,821
| New | +$1.25M |
|
|
VIVO
2178
DELISTED
Meridian Bioscience Inc
VIVO
| $1.22M | ﹤0.01% |
46,931
-17,201
| -27% | -$409K |
|
2179
Deluxe
DLX
$1.24B
| $1.22M | ﹤0.01% |
40,240
-19,679
| -33% | -$618K |
|
2180
Lazard
LAZ
$4.26B
| $1.22M | ﹤0.01% |
35,274
-7,576
| -18% | -$293K |
|
2181
CNO Financial Group
CNO
$5.14B
| $1.22M | ﹤0.01% |
48,506
-142,481
| -75% | -$3.53M |
|
2182
Kaiser Aluminum
KALU
$2.85B
| $1.22M | ﹤0.01% |
12,906
-7,748
| -38% | -$748K |
|
2183
Portillo's
PTLO
$328M
| $1.21M | ﹤0.01% |
+49,438
| New | +$1.31M |
|
2184
Evolent Health
EVH
$350M
| $1.21M | ﹤0.01% |
37,562
-86,667
| -70% | -$2.27M |
|
2185
Dutch Bros
BROS
$8.8B
| $1.21M | ﹤0.01% |
+21,934
| New | +$1.12M |
|
2186
Griffon
GFF
$4.29B
| $1.21M | ﹤0.01% |
60,594
-32,132
| -35% | -$742K |
|
2187
Omega Healthcare
OHI
$14.6B
| $1.21M | ﹤0.01% |
38,853
-68,918
| -64% | -$2.03M |
|
|
SGFY
2188
DELISTED
Signify Health, Inc.
SGFY
| $1.21M | ﹤0.01% |
+66,680
| New | +$956K |
|
|
GRIN
2189
DELISTED
Grindrod Shipping Holdings Ltd. Ordinary Shares
GRIN
| $1.21M | ﹤0.01% |
47,496
+45,546
| +2,336% | +$943K |
|
|
HSKA
2190
DELISTED
Heska Corp
HSKA
| $1.21M | ﹤0.01% |
8,727
-4,134
| -32% | -$585K |
|
2191
Verde Clean Fuels
VGAS
$29.8M
| $1.2M | ﹤0.01% |
+120,400
| New | +$1.2M |
|
|
FINM
2192
DELISTED
Marlin Technology Corporation Class A Ordinary Share
FINM
| $1.2M | ﹤0.01% |
+122,612
| New | +$1.2M |
|
2193
Vaxcyte
PCVX
$7.9B
| $1.2M | ﹤0.01% |
+49,800
| New | +$1.09M |
|
2194
Royal Gold
RGLD
$17.5B
| $1.2M | ﹤0.01% |
8,483
-36,009
| -81% | -$4.21M |
|
|
OSI
2195
DELISTED
Osiris Acquisition Corp.
OSI
| $1.2M | ﹤0.01% |
+123,390
| New | +$1.2M |
|
|
ABTX
2196
DELISTED
Allegiance Bancshares
ABTX
| $1.2M | ﹤0.01% |
26,847
-8,408
| -24% | -$368K |
|
2197
Clearway Energy Class C
CWEN
$4.94B
| $1.2M | ﹤0.01% |
32,794
-134,501
| -80% | -$4.58M |
|
|
GSQD
2198
DELISTED
G Squared Ascend I Inc.
GSQD
| $1.2M | ﹤0.01% |
+121,579
| New | +$1.2M |
|
2199
Green Dot
GDOT
$748M
| $1.2M | ﹤0.01% |
43,519
-26,434
| -38% | -$803K |
|
2200
PUT
UiPath
PATH
$7.31B
| $1.19M | ﹤0.01% |
+55,200
| New | +$1.86M |
|
Similar funds
Barclays's Q1 2022 Portfolio in Review
As of Q1 2022, Barclays held 5,876 positions worth $128B, down 52% from $268B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Barclays withdrew a net $131B in Q1 2022, closing 907 positions and reducing 2,310 holdings. Its most notable exit was Nuance Communications, Inc., an estimated $631M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Barclays opened a new position in Stellantis worth $331M.
- Barclays's largest Q1 2022 buy was Stellantis: 20,333,315 shares worth $331M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.74B increase.
- Barclays's biggest Q1 2022 reduction was Apple, cutting an estimated $1.85B.
- Barclays fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $631M.
- Barclays's ten largest holdings make up 22% of its $128B portfolio in Q1 2022.
- Barclays opened 1,592 new positions and closed 907 in Q1 2022.
- Barclays's portfolio value fell 52% quarter-over-quarter to $128B.
Based on Barclays's 13F filing for Q1 2022, filed 16 May 2022.